The FDA approved the protocol update, significantly expanding patient eligibility criteria for enrollment in the study.

NanoVibronix (Nasdaq:NAOV) today announced that it intends to effect a reverse stock split of its common stock.

Apreo Health announced today that it closed an oversubscribed $130 million Series B financing round to support its Breathe ...

Gentuity announced that it entered into an agreement with GE HealthCare to collaborate on commercial activities for imaging ...

HistoSonics today announced a management-led majority stake acquisition by a syndicate of private and public investors.

Alcon announced today that it entered into a definitive merger agreement through which it acquires Staar Surgical.

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

BiVacor announced today that the FDA accepted its Total Artificial Heart (TAH) into its Total Product LifeCycle Advisory ...

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Keyron announced today that it made significant personnel appointments as it prepares for clinical trials for its ForePass ...

Instylla announced today that it received FDA premarket approval (PMA) for its flagship Embrace hydrogel embolic system (HES) ...

Solventum (NYSE:SOLV) shares rose after hours today on second-quarter results that came in ahead of the consensus forecast.